- Login
- Register & Subscribe
- Language: EN FR DE
Thursday 3 January 2008
Gitte Aabo
Gitte Aabo has become chief executive officer (CEO) of LEO Pharma A/S of Denmark, succeeding Ernst Lunding who has become the company’s chairman and head of the LEO Foundation.
Country: Denmark
Thursday 3 January 2008
Torsten Hombeck
Torsten Hombeck, vice president for finance at GPC Biotech, became chief financial officer on 1 January 2008. He replaces Mirko Scherer who has resigned to pursue other interests.
Country: Germany
Thursday 3 January 2008
Olof Tydén
Italy’s BioXell SpA. has announced the appointment of Prof Olof Tydén to its board of directors.
Country: Italy
Thursday 3 January 2008
Ian Gilham
Ian Gilham has become chief executive officer of Axis-Shield Plc of Scotland, replacing Svein Lien who has left the group. The executive changes took effect on 1 January 2008.
Country: United Kingdom
Thursday 3 January 2008
Thomas Lynch
Thomas Lynch, chairman of Amarin Corp. Plc has been appointed chief executive officer, replacing Rick Stewart who resigned from the company to pursue other business interests.
Country: United Kingdom
Friday 28 December 2007
Nathalie Huitorel
Genfit of France has appointed Nathalie Huitorel as the company’s new vice president for finance, succeeding Stéphane Postic who is leaving the post in order to start his own busin
Country: France
Friday 28 December 2007
Alain Fischer
Cellectis SA of France has appointed Professor Alain Fischer to its scientific advisory board, while Alain Godard has joined the company’s board of directors.
Country: France
Thursday 20 December 2007
John Lechleiter
Eli Lilly and Company has announced that John C.
Country: United States
Wednesday 19 December 2007
Willem de Laat
Top Institute Pharma (TI Pharma) has named Willem de Laat as managing director from 1 January 2008. He will replace Victor J. Nickolson, the founding director, who is retiring.
Country: Netherlands
Wednesday 19 December 2007
Karel Boone
Karel Boone has been named chairman of the Board of Directors of the Belgian biopharmaceutical group, UCB SA, effective 24 April 2008.
Country: Belgium
Tuesday September 7 2010
Friday September 3 2010
Friday August 20 2010
Friday August 20 2010
Thursday August 19 2010